CYNTHIA WISE: Open Payments
NPI 1871078535 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 14 payments from 10 companies in 2025. Trend: 2023 $636 · 2024 $424 · 2025 $346
Food & beverage: $245Education: $101
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Daiichi Sankyo Inc. | 3 | $47 |
| Aveo Pharmaceuticals, Inc. | 1 | $36 |
| GENZYME CORPORATION | 1 | $21 |
| Geron Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: FOTIVDA, Enhertu, SARCLISA, RYTELO, DATROWAY, LUTATHERA, SCEMBLIX, KISQALI.
Industry payments across OK — which companies pay providers there.
